Side Effects of bexarotene: A Synthesis of Findings from 29 Studies
- Home
- Side Effects of bexarotene
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of bexarotene: A Synthesis of Findings from 29 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Bexarotene has been shown to be effective and safe for the treatment of refractory advanced-stage cutaneous T-cell lymphoma (CTCL). 4 Bexarotene is a synthetic retinoid that selectively activates the retinoid X receptor (RXR) subfamily of retinoid receptors, and it has also shown promise in preventing various types of cancer. 21 In addition to its use in CTCL, bexarotene has also been investigated for its potential to protect against traumatic brain injury (TBI) in mice. 28 Bexarotene has also been researched for its potential to alleviate positive symptoms in patients with schizophrenia. 6 A study showed that bexarotene, when used in combination with phototherapy, might be a therapeutic option for early-stage mycosis fungoides (MF). 1 Research suggests bexarotene is a promising candidate for the treatment of COVID-19. 5
Reasons for Side Effects
The side effects of bexarotene are mainly due to the activation of RXR, which can cause changes in gene expression and disrupt cellular processes. 21 Additionally, bexarotene can accumulate in the liver, leading to liver dysfunction and lipid metabolism disorders. 21
Common Side Effects
Hyperlipidemia
Bexarotene can cause hyperlipidemia, resulting in elevated levels of triglycerides and cholesterol in the blood. 7 27 24 14 18 This is often attributed to the metabolism of bexarotene in the liver. 21 It's important to monitor lipid levels as hyperlipidemia can increase the risk of heart disease and stroke. 7
Hypothyroidism
Bexarotene can lead to hypothyroidism, characterized by reduced thyroid hormone production due to the suppression of thyroid-stimulating hormone (TSH) secretion. 3 18 14 Hypothyroidism can cause fatigue, weight gain, and sensitivity to cold. 3
Hepatic Dysfunction
Bexarotene can cause hepatic dysfunction, which may involve elevated liver enzyme levels or liver inflammation. 21 29 Symptoms of hepatic dysfunction can include jaundice, abdominal pain, and loss of appetite. 21
Other Side Effects
Other side effects reported with bexarotene include rashes, itching, hair loss, gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, dizziness, vision problems, muscle aches, joint pain, weight gain, and swelling. 2 14 21 16 29
Side Effect Management
Hyperlipidemia
Hyperlipidemia can be managed through dietary and exercise modifications. 7 Lipid-lowering medications might be prescribed if necessary. 7 Preventing hyperlipidemia involves consuming a low-fat diet and engaging in regular exercise. 7
Hypothyroidism
Hypothyroidism is treated with thyroid hormone replacement therapy. 3 Thyroid hormone replacement therapy supplements the deficient thyroid hormone levels and helps alleviate symptoms. 3
Hepatic Dysfunction
Hepatic dysfunction might necessitate discontinuation or dosage reduction of bexarotene. 21 29 Liver-protective medications may also be administered. 21 Prevention of hepatic dysfunction involves avoiding excessive alcohol consumption and maintaining a balanced diet. 21 29
Comparison Between Studies
Similarities
Several studies have reported that bexarotene can cause side effects such as hyperlipidemia, hypothyroidism, and hepatic dysfunction. 7 27 24 14 18 3 21 29 Bexarotene can also cause skin inflammation, dryness, and hair loss. 22
Differences
The frequency and severity of side effects can vary across studies. This variability is likely influenced by factors such as bexarotene dosage, treatment duration, and patient age and characteristics. 29 For example, one study might report more frequent instances of hyperlipidemia compared to another study. 7 27 Similarly, the occurrence of hepatic dysfunction has been reported differently in various studies. 21 29
Cautions Regarding Real-Life Applications
Bexarotene holds the potential to be a valuable therapeutic agent for various conditions. However, it is crucial to use it under the guidance of a healthcare professional, being aware of the possibility of hyperlipidemia, hypothyroidism, hepatic dysfunction, and other side effects. 7 21 29 Specifically, pregnant or breastfeeding women should consult their physician before taking bexarotene. 7 21 29
Limitations of Current Research
Research on the side effects of bexarotene is still ongoing. More long-term clinical trials and epidemiological studies are needed, particularly to better understand long-term side effects. 29 Predicting the occurrence and severity of bexarotene side effects can be challenging as they vary among individuals. 29
Future Research Directions
To gain a deeper understanding of bexarotene's side effects, long-term clinical trials and epidemiological studies are essential. Research on strategies to mitigate side effects and identify patients at higher risk of experiencing side effects is also crucial. 29
Conclusion
Bexarotene holds the potential to be a valuable treatment for a range of conditions, including CTCL and other cancers. However, it's important to be aware of its potential side effects, such as hyperlipidemia, hypothyroidism, and hepatic dysfunction. If you are considering taking bexarotene, consult with your physician to weigh the risks and benefits and ensure that the medication is right for you. 21 29
Benefit Keywords
Risk Keywords
Article Type
Author: GinsburgErica, HennessyKerry, MhaskarRahul, Seminario-VidalLucia
Language : English
Author: BrownJ William L, CunniffeNick G, PradosFerran, KanberBaris, JonesJoanne L, NeedhamEdward, GeorgievaZoya, RogDavid, PearsonOwen R, OverellJames, MacManusDavid, SamsonRebecca S, StuttersJonathan, Ffrench-ConstantCharles, Gandini Wheeler-KingshottClaudia A M, MoranCarla, FlynnPaul D, MichellAndrew W, FranklinRobin J M, ChandranSiddharthan, AltmannDaniel R, ChardDeclan T, ConnickPeter, ColesAlasdair J
Language : English
Author: Graeppi-DulacJulia, Vlaeminck-GuillemVirginie, Perier-MuzetMarie, DalleStéphane, OrgiazziJacques
Language : English
Author: DuvicM, HymesK, HealdP, BrenemanD, MartinA G, MyskowskiP, CrowleyC, YocumR C,
Language : English
Author: YuanShuofeng, ChanJasper F W, ChikKenn K H, ChanChris C Y, TsangJessica O L, LiangRonghui, CaoJianli, TangKaiming, ChenLin-Lei, WenKun, CaiJian-Piao, YeZi-Wei, LuGang, ChuHin, JinDong-Yan, YuenKwok-Yung
Language : English
Author: LernerVladimir, MiodownikChanoch, GibelAnatoly, SirotaPinchas, BushIlan, ElliotHadi, BenatovRuben, RitsnerMichael S
Language : English
Author: ChenLijiang, WangYongjie, ZhangJiaozhen, HaoLeilei, GuoHejian, LouHongxiang, ZhangDianrui
Language : English
Author: JurutkaPeter W, di MartinoOrsola, ReshiSabeeha, MallickSanchita, SabirZhela L, StaniszewskiLech J P, WardaAnkedo, MaiorellaEmma L, MinasianAni, DavidsonJesse, IbrahimSamir J, RabanSan, HaddadDena, KhamisiMadleen, SubanStephanie L, DawsonBradley J, CandiaRiley, ZillerJoseph W, LeeMing-Yue, LiuChang, LiuWei, MarshallPamela A, WelchJohn S, WagnerCarl E
Language : English
Author: HuenAuris O, KimEllen J
Language : English
Author: ZhangQi, LeeSang Beom, ChenXu, StevensonMorgan E, PanJing, XiongDonghai, ZhouYu, MillerMark Steven, LubetRonald A, WangYian, MirzaShama P, YouMing
Language : English
Author: ShenDanyang, YuXiaoming, WuYan, ChenYuanlei, LiGonghui, ChengFeng, XiaLiqun
Language : English
Author: FidanOzkan, MujwarSomdutt, KciukMateusz
Language : English
Author: PierrotNathalie, LhommelRenaud, QuenonLisa, HanseeuwBernard, DricotLaurence, SindicChristian, MaloteauxJean-Marie, OctaveaJean-Noël, IvanoiuAdrian
Language : English
Author: DuvicM
Language : English
Author: YangHua, MaPengcheng, CaoYuping, ZhangMengli, LiLingjun, WeiJun, TaoLei, QianKun
Language : English
Author: TaiLeon M, KosterKevin P, LuoJia, LeeSue H, WangYue-Ting, CollinsNicole C, Ben AissaManel, ThatcherGregory R J, LaDuMary Jo
Language : English
Author: KannangaraAjith P, LevitanDenise, FleischerAlan B
Language : English
Language : Czech
Author: GretskayaNatalia M, GamisoniaAlina M, DudinaPolina V, ZakharovStanislav S, SherstyanykhGalina, AkasovRoman, BurovSergey, SerkovIgor V, AkimovMikhail G, BezuglovVladimir V, MarkvichevaElena
Language : English
Author: KaemmererTill, StadlerPia-Charlotte, Helene FrommherzLeonie, GuertlerAnne, Einar FrenchLars, ReinholzMarkus
Language : English
Author: QiLisi, GuoYuanyuan, ZhangPei, CaoXiaorong, LuanYuxia
Language : English
Author: MesserschmidtA, SchultheisK, OchsendorfF
Language : German
Author: SternDana Kaslow, LebwohlMark
Language : English
Author: LasaOlatz, IzuRosa, AceboElvira, EguinoPatricia, Díaz-PérezJosé L
Language : Spanish
Author: DelfinoC, GrandiV, PileriA, RupoliS, QuaglinoP, AlteriniR, GoteriG, CanafogliaL, PimpinelliN
Language : English
Author: ZhangChunlei, DuvicMadeleine
Language : English
Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention.
Author: ZhangDi, LealAna S, CarapellucciSarah, ShahaniPritika H, BhogalJaskaran S, IbrahimSamir, RabanSan, JurutkaPeter W, MarshallPamela A, SpornMichael B, WagnerCarl E, LibyKaren T
Language : English
Author: ZhongJianjun, ChengChongjie, LiuHan, HuangZhijian, WuYue, TengZhipeng, HeJunchi, ZhangHongrong, WuJinchuan, CaoFang, JiangLi, SunXiaochuan
Language : English
Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1.
Author: TachibanaMasaya, ShinoharaMitsuru, YamazakiYu, LiuChia-Chen, RogersJustin, BuGuojun, KanekiyoTakahisa
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.